These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 28262011)

  • 21. Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India.
    Babu BV; Kar SK
    Trop Med Int Health; 2004 Jun; 9(6):702-9. PubMed ID: 15189460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conclusions of the meeting of the Technical Advisory Group on the Global Elimination of Lymphatic Filariasis, November 2007.
    Wkly Epidemiol Rec; 2008 Sep; 83(37):341-7. PubMed ID: 18788147
    [No Abstract]   [Full Text] [Related]  

  • 23. Towards elimination of lymphatic filariasis: social mobilization issues and challenges in mass drug administration with anti-filarial drugs in Tamil Nadu, South India.
    Nandha B; Krishnamoorthy K; Jambulingam P
    Health Educ Res; 2013 Aug; 28(4):591-8. PubMed ID: 23503571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progress towards, and challenges for, the elimination of filariasis from Pacific-island communities.
    Burkot TR; Taleo G; Toeaso V; Ichimori K
    Ann Trop Med Parasitol; 2002 Dec; 96 Suppl 2():S61-9. PubMed ID: 12625919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meeting of the International Task Force for Disease Eradication – July 2013.
    Wkly Epidemiol Rec; 2013 Oct; 88(40):430-4. PubMed ID: 24159665
    [No Abstract]   [Full Text] [Related]  

  • 26. Lymphatic filariasis in the Eastern Mediterranean Region: current status and prospects for elimination.
    El Setouhy M; Ramzy RM
    East Mediterr Health J; 2003 Jul; 9(4):534-41. PubMed ID: 15748050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elimination of lymphatic filariasis.
    Wkly Epidemiol Rec; 2002 May; 77(22):177-9. PubMed ID: 12061029
    [No Abstract]   [Full Text] [Related]  

  • 28. Disease eradication.
    Hopkins DR
    N Engl J Med; 2013 Jan; 368(1):54-63. PubMed ID: 23281976
    [No Abstract]   [Full Text] [Related]  

  • 29. Progress towards eliminating lymphatic filariasis in Zanzibar: a model programme.
    Mohammed KA; Molyneux DH; Albonico M; Rio F
    Trends Parasitol; 2006 Jul; 22(7):340-4. PubMed ID: 16713740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meeting of the International Task Force for Disease Eradication--12 May 2006.
    Wkly Epidemiol Rec; 2007 Jan; 82(4):25-30. PubMed ID: 17256204
    [No Abstract]   [Full Text] [Related]  

  • 31. Towards the elimination of lymphatic filariasis.
    Dean M
    Lancet; 2002 May; 359(9318):1677. PubMed ID: 12020539
    [No Abstract]   [Full Text] [Related]  

  • 32. Preventing confusion about side effects in a campaign to eliminate lymphatic filariasis.
    Ramaiah KD; Ravi R; Das PK
    Trends Parasitol; 2005 Jul; 21(7):307-8. PubMed ID: 15923141
    [No Abstract]   [Full Text] [Related]  

  • 33. Global programme to eliminate lymphatic filariasis.
    Wkly Epidemiol Rec; 2007 Oct; 82(42):361-80. PubMed ID: 17948605
    [No Abstract]   [Full Text] [Related]  

  • 34. Adverse reactions following mass drug administration during the Programme to Eliminate Lymphatic Filariasis in Orissa State, India.
    Babu BV; Rath K; Kerketta AS; Swain BK; Mishra S; Kar SK
    Trans R Soc Trop Med Hyg; 2006 May; 100(5):464-9. PubMed ID: 16288792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study on the factors affecting the MDA programme in Kerala state.
    Showkath Ali MK; Rajendran R; Regu K; Mohanan MK; Dhariwal AC; Lal S
    J Commun Dis; 2007 Mar; 39(1):51-6. PubMed ID: 18338717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elimination of lymphatic filariasis.
    Michael E; Malecela-Lazaro MN; Kazura JW
    Lancet; 2006 Jul; 368(9533):362-3; author reply 363-4. PubMed ID: 16876654
    [No Abstract]   [Full Text] [Related]  

  • 37. Eliminating lymphatic filariasis--the surveillance challenge.
    Huppatz C; Durrheim D; Lammie P; Kelly P; Melrose W
    Trop Med Int Health; 2008 Mar; 13(3):292-4. PubMed ID: 18397392
    [No Abstract]   [Full Text] [Related]  

  • 38. Field application of PCR-based assays for monitoring Wuchereria bancrofti infection in Africa.
    Ramzy RM
    Ann Trop Med Parasitol; 2002 Dec; 96 Suppl 2():S55-9. PubMed ID: 12625918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Meeting of the International Task Force for Disease Eradication, November 2015.
    Wkly Epidemiol Rec; 2016 Feb; 91(6):61-71. PubMed ID: 26875204
    [No Abstract]   [Full Text] [Related]  

  • 40. Limitation and facilitation in the vectors and other aspects of the dynamics of filarial transmission: the need for vector control against Anopheles-transmitted filariasis.
    Pichon G
    Ann Trop Med Parasitol; 2002 Dec; 96 Suppl 2():S143-52. PubMed ID: 12625927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.